Brinkschulte, Rebecca
Fußhöller, David M.
Hoss, Florian http://orcid.org/0000-0002-9231-5848
Rodríguez-Alcázar, Juan F.
Lauterbach, Mario A.
Kolbe, Carl-Christian
Rauen, Melanie
Ince, Semra
Herrmann, Christian
Latz, Eicke http://orcid.org/0000-0003-1488-5666
Geyer, Matthias http://orcid.org/0000-0002-7718-5002
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC2151–390873048)
Else Kröner-Fresenius-Stiftung (2014_A203)
Article History
Received: 11 June 2021
Accepted: 17 October 2022
First Online: 3 November 2022
Competing interests
: The authors declare the following competing interests: M.G. and E.L. are co-founders and consultants of IFM Therapeutics. The other authors declare no competing interests.